Abingworth is an international investment group dedicated exclusively to the life sciences and healthcare sector. The company invests at all stages of development including early and late-stage venture financing, growth equity and public companies.
Founded in 1973, Abingworth has a lengthy track record of backing market leading companies. Abingworth has a specialist team of 19 professionals with a broad range of skill sets and access to an extensive network of industry contacts. Abingworth has funds under management of over $1.25 billion and offices in London, Menlo Park ( California) and Boston.
Clarus Ventures is a life sciences venture capital firm founded by a team of accomplished investment and operating professionals. The investment team has extensive and broad backgrounds in research and development, commercialization, business development and operations management, which enabled Clarus to establish a long history of success in creating value across multiple disciplines within the healthcare-investing universe. The deep domain expertise of the Clarus team allows us to employ a hands-on philosophy of providing value enhanced leadership and guidance in working with our management teams in both the biopharmaceutical and medical device arenas. Clarus is presently managing $1.2 billion. The firm invests globally out of its offices in Cambridge, MA and South San Francisco, CA.Contacts For Avillion Lewis Cameron CEO Tel: +44(0)207470-2458 email@example.com http://www.avillionllp.com For Abingworth Genghis Lloyd-Harris Partner Tel: +44(0)20-7534-1500 firstname.lastname@example.org http://www.abingworth.com For Clarus Kurt Wheeler Managing Director Tel: +1-(650)-238-5055 email@example.com http://www.clarusventures.com SOURCE Avillion LLP